SLC6A14 has been shown to be such a cancer-specific amino acid transporter: it is highly expressed in estrogen receptor-positive (ER+) breast cancers and pancreatic cancer, but low in normal tissues [21]. Here, SLC38A7 is linked to breast cancer.